Filed with the SEC as Chernett Jorey; the order above is the one the filer's own signature uses.
In the 12 months to Nov 19, 2026, on the open market: bought $1.3M of STLN, STIM, XGN; sold $16.7M of STLN, STIM, XGN. Filed a median of 1 business day after the trade.
Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these
Insider purchases above the line: $1.3MInsider sales below: $16.7M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.
STIMSold: Neuronetics, Inc. Nov 13, 20262,187,051 sharesfiled Nov 13, 20267,325,577 shares held directly after, as filedfiling$2.5M
XGNSold: EXAGEN INC. Nov 13, 202658,068 sharesfiled Nov 13, 20262,529,436 shares held directly after, as filedfiling$237K
STIMSold: Neuronetics, Inc. Nov 12, 2026706,840 sharesfiled Nov 13, 20269,512,628 shares held directly after, as filedfiling$1.0M
XGNSold: EXAGEN INC. Nov 12, 2026109,436 sharesfiled Nov 13, 20262,587,504 shares held directly after, as filedfiling$509K
XGNBought: EXAGEN INC. Nov 11, 202671,315 sharesfiled Nov 12, 20262,696,940 shares held directly after, as filedfiling$373K
STIMSold: Neuronetics, Inc. Nov 11, 202686,757 sharesfiled Nov 13, 202610,219,468 shares held directly after, as filedfiling$140K
XGNBought: EXAGEN INC. Nov 10, 20267,085 sharesfiled Nov 10, 20262,625,625 shares held directly after, as filedfiling$37K
STIMSold: Neuronetics, Inc. Nov 9, 2026103,959 sharesfiled Nov 13, 202610,266,225 shares held directly after, as filedfiling$214K
STLNBought: Starling Oncology, Inc. Nov 9, 202648,294 sharesfiled Nov 10, 20267,858,091 shares held directly after, as filedfiling$176K
STIMBought: Neuronetics, Inc. Nov 9, 202640,000 sharesfiled Nov 13, 202610,306,225 shares held directly after, as filedfiling$80K
XGNBought: EXAGEN INC. Nov 9, 20268,500 sharesfiled Nov 10, 20262,618,540 shares held directly after, as filedfiling$54K
STLNSold: Starling Oncology, Inc. Nov 6, 20262,851,061 sharesfiled Nov 10, 20267,809,797 shares held directly after, as filedfiling$11.4M
STIMSold: Neuronetics, Inc. Nov 6, 2026250,804 sharesfiled Nov 13, 202610,370,184 shares held directly after, as filedfiling$599K
XGNSold: EXAGEN INC. Nov 6, 202611,265 sharesfiled Nov 10, 20262,610,040 shares held directly after, as filedfiling$69K
STIMBought: Neuronetics, Inc. Oct 30, 202618,000 sharesfiled Nov 2, 202610,620,988 shares held directly after, as filedfiling$41K
XGNBought: EXAGEN INC. Oct 19, 202614,000 sharesfiled Oct 20, 20262,618,540 shares held directly after, as filedfiling$104K
STLNBought: Starling Oncology, Inc. Aug 14, 202612,000 sharesfiled Aug 17, 202610,660,858 shares held directly after, as filedfiling$78K
STIMBought: Neuronetics, Inc. Aug 14, 202614,000 sharesfiled Aug 17, 202610,602,988 shares held directly after, as filedfiling$44K
STLNBought: Oncology Institute, Inc. Jul 21, 202618,000 sharesfiled Jul 22, 202610,648,858 shares held directly after, as filedfiling$95K
STIMBought: Neuronetics, Inc. Jul 14, 202635,000 sharesfiled Jul 15, 202610,588,988 shares held directly after, as filedfiling$62K
STLNBought: Oncology Institute, Inc. Jul 10, 202615,000 sharesfiled Jul 13, 202610,630,858 shares held directly after, as filedfiling$88K
STLNBought: Oncology Institute, Inc. Jun 23, 202618,000 sharesfiled Jun 24, 202610,615,858 shares held directly after, as filedfiling$90K
Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.
Stakes filed (13D/13G)
Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Filings made under this filer's SEC CIK in the same 12 months, newest first; the figure is the percentage the filing states. Every recent 13D and 13G